Drug Search by Year (Detail)

24983455

US

Drug ineffective, Malignant neoplasm progression, Metastases to central nervous system,

ETOPOSIDE, CISPLATIN, ATEZOLIZUMAB, CARBOPLATIN, DURVALUMAB,

24983562

US

Malignant neoplasm progression, Drug ineffective, Off label use,

DOXORUBICIN, ETOPOSIDE, CISPLATIN, CISPLATIN, PACLITAXEL, PACLITAXEL, IFOSFAMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, FAMOTIDINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED,

24983584

BR

Malignant neoplasm progression, Erectile dysfunction, Confusional state,

LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, AMLODIPINE,

24983587

AU

Malignant neoplasm progression, Drug ineffective, Myoclonus, Somnolence, Confusional state,

PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, FENTANYL,

24983645

US

Malignant neoplasm progression, Drug ineffective,

PEMETREXED, PEMETREXED DISODIUM, DOCETAXEL, DOCETAXEL ANHYDROUS, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, CARBOPLATIN, RAMUCIRUMAB, PACLITAXEL,

24983815

ES

Malignant neoplasm progression, Drug ineffective,

24983840

ES

Malignant neoplasm progression, Drug ineffective,

24984190

CA

Full blood count abnormal, Emotional distress, Hepatic neoplasm, Hypotension, Vomiting, Neuroendocrine tumour, Anxiety, Inappropriate schedule of product administration, Nausea, Blood pressure increased, Abdominal pain, Tremor, Dyspepsia, Diarrhoea, Muscle spasms, Nasopharyngitis, Asthenia, Second primary malignancy, Fatigue, Malignant neoplasm progression, Cough, Ear infection, Abdominal pain upper, Cystitis, Pyrexia, Disturbance in attention, Lung neoplasm malignant,

OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, CYCLOBENZAPRINE, SERTRALINE, SERTRALINE, RAMIPRIL, IRBESARTAN, QUETIAPINE FUMARATE, QUETIAPINE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, BUPROPION HYDROCHLORIDE, BUPROPION, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, MAGNESIUM CHLORIDE, CELECOXIB, CLONAZEPAM,

24984520

IN

Off label use, Haemoglobin decreased, White blood cell count decreased, Platelet count decreased, Blood albumin decreased, Malaise, Liver function test abnormal, Platelet count abnormal, Malignant neoplasm progression, Multiple organ dysfunction syndrome,

ATEZOLIZUMAB, ATEZOLIZUMAB, ATEZOLIZUMAB,

24984662

ES

Malignant neoplasm progression, Drug ineffective,

24984668

JP

Swelling of eyelid, Neuropathy peripheral, Malignant neoplasm progression,

ZOLBETUXIMAB, OXALIPLATIN, CAPECITABINE,

24985050

CA

Off label use, Lung neoplasm malignant, Malignant neoplasm progression, Metastases to bone, Metastases to liver,

OCTREOTIDE ACETATE,

24985544

JP

White blood cell count decreased, Exostosis of jaw, Malignant neoplasm progression,

DURVALUMAB, DURVALUMAB, TREMELIMUMAB, TREMELIMUMAB, CARBOPLATIN, PACLITAXEL,

24985565

CA

Weight increased, Asthenia, Abdominal pain, Blister, Blood creatine phosphokinase increased, Blood iron decreased, Blood magnesium decreased, Blood pressure decreased, Blood pressure diastolic decreased, Blood pressure systolic decreased, Blood test abnormal, Breast disorder, Constipation, Dry mouth, Dry skin, Dry throat, Dysmenorrhoea, Eczema, Electric shock sensation, Epistaxis, Faeces soft, Fatigue, Gingival pain, Hand dermatitis, Headache, Heart rate decreased, Hepatitis, Hyperaesthesia, Hypotension, Malaise, Malignant neoplasm progression, Muscular weakness, Myalgia, Nasopharyngitis, Nausea, Neoplasm progression, Pain, Palpitations, Paraesthesia, Pruritus, Recurrent cancer, Seasonal allergy, Skin fissures, Sneezing, Stress, Tumour marker increased, Urinary tract infection, Vulvovaginal pain, Weight decreased,

HUMAN IMMUNOGLOBULIN G, ADO-TRASTUZUMAB EMTANSINE, ADO-TRASTUZUMAB EMTANSINE, CAPECITABINE, PERTUZUMAB, PERTUZUMAB, TRASTUZUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, MAGNESIUM, PACLITAXEL, METHYLPREDNISOLONE, TRAMADOL HYDROCHLORIDE,

24985817

CN

Drug ineffective, Decreased appetite, Hepatic enzyme increased, Hepatotoxicity, Insomnia, Malignant neoplasm progression, Vomiting,

ANASTROZOLE, LETROZOLE, RIBOCICLIB, PREDNISONE,

24985887

GB

Metastatic malignant melanoma, Malignant neoplasm progression, Nausea, Prescribed underdose, Off label use,

ENCORAFENIB, BINIMETINIB, NIVOLUMAB,

24985923

US

Blindness unilateral, Lung carcinoma cell type unspecified stage IV, Malignant neoplasm progression, Breast cancer, Eating disorder, Nausea, Hypoacusis, Chronic obstructive pulmonary disease, Burn oesophageal, Blood cholesterol increased, Hypertension, Blood pressure decreased, Weight decreased, Dysphagia, Gallbladder polyp, Abdominal discomfort, Product substitution issue, Product use issue,

ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM, ROFLUMILAST, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL, OLMESARTAN MEDOXOMIL,

24985938

JP

Death, Anaemia, Febrile neutropenia, Rash, Malignant neoplasm progression,

DURVALUMAB, TREMELIMUMAB, CARBOPLATIN, PACLITAXEL,

24985990

US

Malignant neoplasm progression, Fatigue,

ABEMACICLIB, FULVESTRANT, DENOSUMAB,

24986004

JP

Malignant neoplasm progression, Cardiac failure congestive, Embolism venous, Immune-mediated adrenal insufficiency, Pulmonary embolism, Neutrophil count decreased,

PEMBROLIZUMAB, GEMCITABINE HYDROCHLORIDE, CARBOPLATIN,

24986081

RU

Death, Malignant neoplasm progression, Thrombocytopenia, Neoplasm malignant, Neurological symptom, Condition aggravated, Weight decreased,

24986450

PH

Malignant neoplasm progression, Oncologic complication,

OSIMERTINIB,

24986489

ES

Gastrointestinal stromal tumour, Malignant neoplasm progression,

IMATINIB,

24986735

JP

Malignant neoplasm progression, Pleurisy, Bladder tamponade, Ovarian enlargement, Hydronephrosis, Blindness, Collagen disorder, Postrenal failure, Scleritis,

PEMBROLIZUMAB, PEMBROLIZUMAB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MIGLITOL, CANDESARTAN, ROSUVASTATIN, CISPLATIN, GEMCITABINE HYDROCHLORIDE,

24987367

US

Malignant neoplasm progression, Chemotherapy,

PEMBROLIZUMAB, LENVATINIB,

24987505

US

Biliary obstruction, Malignant neoplasm progression, Off label use, Blood bilirubin increased, Decreased appetite, Fatigue, Nausea,

CETUXIMAB, ENCORAFENIB, ENCORAFENIB, ENCORAFENIB,

24987512

JP

Malignant neoplasm progression, Performance status decreased,

NECITUMUMAB, GEMCITABINE HYDROCHLORIDE, CISPLATIN,

24987564

JP

Death, Malignant neoplasm progression, Pneumonia aspiration, Interstitial lung disease, Malaise, Blood creatinine increased,

PEMBROLIZUMAB,

24987897

CA

Malignant neoplasm progression, Product use in unapproved indication,

BEVACIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, TISOTUMAB VEDOTIN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ACETAMINOPHEN,

24978551

US

Malignant neoplasm progression, Pulmonary embolism, Hypoxia,

LENALIDOMIDE, CELECOXIB, LOSARTAN POTASSIUM, ATORVASTATIN CALCIUM, NIACIN, AMLODIPINE BESYLATE, PROCHLORPERAZINE, LEVOTHYROXINE SODIUM,

24978939

AT

Malignant neoplasm progression, Surgery, Chemotherapy, Radiotherapy,

PEMBROLIZUMAB, PEMBROLIZUMAB,

24979812

BE

Gastrointestinal stromal tumour, Malignant neoplasm progression,

IMATINIB, CABOZANTINIB, REGORAFENIB,

24979891

US

Malignant neoplasm progression, Blood pressure decreased, Rash, Skin mass, Pruritus, Pharyngeal ulceration, Rash,

PEMBROLIZUMAB, FAMOTIDINE, PACLITAXEL, CISPLATIN, CARBOPLATIN,

24980077

JP

Malignant neoplasm progression, Meningitis, Hepatic function abnormal,

PEMBROLIZUMAB, CARBOPLATIN, PEMETREXED DISODIUM, PEMETREXED,

24980514

JP

Malignant neoplasm progression, Palmar-plantar erythrodysaesthesia syndrome,

ZOLBETUXIMAB,

24981187

PL

Malignant neoplasm progression, Demyelination, Prescribed underdose, Neurodegenerative disorder,

NIVOLUMAB, IPILIMUMAB, PACLITAXEL, CARBOPLATIN,

24982092

AR

Drug ineffective, Product supply issue, Abdominal mass, Fluid retention, Malignant neoplasm progression, Breast cancer metastatic,

RIBOCICLIB, ENALAPRIL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, LEVOTHYROXINE, ALBUTEROL SULFATE, ALBUTEROL, IPRATROPIUM BROMIDE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE,

24982312

BR

Gastrointestinal infection, Bacterial diarrhoea, Pleural effusion, Malignant neoplasm progression, Anaemia, Asthenia,

ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, DENOSUMAB,

24982691

JP

Malignant neoplasm progression, Immune-mediated dermatitis,

PEMBROLIZUMAB,

24982716

AU

Malignant neoplasm progression,

LENVATINIB, PEMBROLIZUMAB,

24982769

JP

Malignant neoplasm progression, Immune-mediated hepatic disorder, Amylase increased, Immune-mediated dermatitis, Anaemia,

PEMBROLIZUMAB,

24982811

MY

Breast cancer, Malignant neoplasm progression, Drug ineffective,

RIBOCICLIB,

24983074

US

Drug ineffective, Malignant neoplasm progression,

ETOPOSIDE, CARBOPLATIN, ATEZOLIZUMAB, LISINOPRIL, DOXAZOSIN, DOXAZOSIN MESYLATE,

24983140

US

Drug ineffective for unapproved indication, Malignant neoplasm progression,

ETOPOSIDE, CISPLATIN, MITOTANE, NIVOLUMAB, IPILIMUMAB, DOXORUBICIN HYDROCHLORIDE,

24983162

US

Thrombocytopenia, Drug ineffective, Malignant neoplasm progression, Off label use,

DOXORUBICIN, DOXORUBICIN, ETOPOSIDE, CISPLATIN, CISPLATIN, CISPLATIN, PACLITAXEL, PACLITAXEL, PACLITAXEL, IFOSFAMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, FAMOTIDINE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE,

24983166

US

Malignant neoplasm progression, Drug ineffective for unapproved indication,

ETOPOSIDE, ALLOPURINOL, IFOSFAMIDE, CISPLATIN,

24983200

DO

Breast cancer, Malignant neoplasm progression, Tumour marker increased,

RIBOCICLIB,

24985852

Malignant neoplasm progression, Therapy change,

24974251

JP

Malignant neoplasm progression, Blood glucose increased, Malaise,

ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN,

24974979

KR

Malignant neoplasm progression, Treatment failure,

ZANUBRUTINIB, ZANUBRUTINIB,

24975016

BR

Malignant neoplasm progression, Incorrect route of product administration,

LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE,

24975166

JP

Metastases to peritoneum, Malignant neoplasm progression,

ENFORTUMAB VEDOTIN,

24975961

US

Malignant neoplasm progression, Haemoglobin decreased, Platelet count decreased, Decreased appetite, Weight decreased, Fatigue, Nausea,

NIRAPARIB, NIRAPARIB,

24976210

CH

Drug-induced liver injury, Diabetes mellitus, Malignant neoplasm progression,

PACLITAXEL, ATEZOLIZUMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, GEMCITABINE HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, LACTULOSE, MAGNESIUM, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION,

24976369

CA

Hepatic cancer stage IV, Metastases to spine, Portal hypertension, Aortic arteriosclerosis, Hepatic cirrhosis, Hepatic steatosis, Malignant neoplasm progression,

ROSUVASTATIN CALCIUM, DAPAGLIFLOZIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BISOPROLOL FUMARATE, DAPAGLIFLOZIN, PANTOPRAZOLE,

24976713

IN

Cardiac arrest, Pulmonary oedema, Malignant neoplasm progression, Drug ineffective, Dyspnoea,

ALECTINIB HYDROCHLORIDE, ALECTINIB HYDROCHLORIDE,

24977157

DE

Suicide attempt, Malignant neoplasm progression, Breast fibrosis, Breast pain, Joint deposit, Spinal disorder, Posture abnormal, Kidney enlargement, Bone metabolism disorder, Mental disorder, Limb discomfort, Food poisoning, Oral disorder, Osteoarthritis, Osteochondrosis, Product intolerance, Anxiety, Diarrhoea,

ABEMACICLIB, CAPECITABINE, DENOSUMAB, GOSERELIN,

24977353

DE

Malignant neoplasm progression, Gamma-glutamyltransferase increased,

PEMBROLIZUMAB,

24977490

BE

Gastrointestinal stromal tumour, Malignant neoplasm progression,

REGORAFENIB, IMATINIB, CABOZANTINIB,

24977547

JP

Pneumonia aspiration, Malignant neoplasm progression,

DURVALUMAB, TREMELIMUMAB, CARBOPLATIN, PACLITAXEL,

24977917

JP

Malignant neoplasm progression, Pulmonary toxicity,

PEMBROLIZUMAB,

24978232

US

Prostate cancer, Metastases to bone, Malignant neoplasm progression, Prostatic specific antigen increased, Drug ineffective,

LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN,

24973310

JP

Malignant neoplasm progression, Fulminant type 1 diabetes mellitus, Interstitial lung disease,

PEMBROLIZUMAB, CARBOPLATIN, PACLITAXEL,

24967982

AU

Malignant neoplasm progression,

BORTEZOMIB FOR INJECTION, BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, SELINEXOR, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM,

24968094

US

Malignant neoplasm progression,

TIVOZANIB,

24968404

US

Malignant neoplasm progression,

ABEMACICLIB,

24968455

US

Hydronephrosis, Bladder mass, Malignant neoplasm progression,

LEUPROLIDE ACETATE,

24968601

DE

Malignant neoplasm progression,

SELINEXOR, BORTEZOMIB FOR INJECTION, BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ACYCLOVIR, OLANZAPINE, PANTOPRAZOLE, CICLOPIROX, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ENOXAPARIN SODIUM, GRANISETRON, GRANISETRON HYDROCHLORIDE, APREPITANT, LACTULOSE, MAGNESIUM OXIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL,

24969016

CA

Malignant neoplasm progression,

OLAPARIB,

24969083

FR

Pyelonephritis, Malignant neoplasm progression, Streptococcal bacteraemia, Dermo-hypodermitis, Arthritis bacterial,

PACLITAXEL, PACLITAXEL, PACLITAXEL, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, DOSTARLIMAB, DOSTARLIMAB, DOSTARLIMAB,

24969233

KR

Femur fracture, Malignant neoplasm progression, Metastases to lymph nodes, Metastases to central nervous system, Metastases to pleura, Metastases to bone,

GEFITINIB, OSIMERTINIB,

24970063

JP

Malignant neoplasm progression, Renal impairment, Thrombotic microangiopathy,

PEMBROLIZUMAB,

24970387

JP

Malignant neoplasm progression, Immune-mediated gastritis, Duodenitis,

PEMBROLIZUMAB,

24970763

JP

Malignant neoplasm progression, Brain natriuretic peptide increased, Cardiotoxicity,

PEMBROLIZUMAB, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, CISPLATIN,

24970983

IT

Off label use, Death, Malignant neoplasm progression,

TRIPTORELIN, TRIPTORELIN, BICALUTAMIDE, NERATINIB,

24971191

US

Breast cancer, Osteonecrosis of jaw, Malignant neoplasm progression, Nausea, Vomiting,

LENVATINIB, LENVATINIB, LENVATINIB, LENVATINIB, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), HYDROCHLOROTHIAZIDE,

24971260

AU

Malignant neoplasm progression,

DOSTARLIMAB,

24971400

JP

Malignant neoplasm progression,

PEMBROLIZUMAB, GEMCITABINE HYDROCHLORIDE, CISPLATIN,

24971780

Failure to thrive, Peripheral T-cell lymphoma unspecified stage IV, Adult T-cell lymphoma/leukaemia, Malignant neoplasm progression, Malignant mesenteric neoplasm, Aortic disorder, Neoplasm malignant, Cutaneous T-cell lymphoma, Abdominal pain,

ROMIDEPSIN, ROMIDEPSIN, BENDAMUSTINE HCL, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE,

24963041

FR

Malignant neoplasm progression, Obstruction,

OLAPARIB,

24963403

US

Neuropathy peripheral, Malignant neoplasm progression, Arthralgia, Back pain, Restless legs syndrome, Fatigue,

ENZALUTAMIDE,

24963727

NL

Malignant neoplasm progression,

LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE,

24963747

US

Malignant neoplasm progression, Skin lesion, Depression, Dry skin,

RIPRETINIB,

24963750

CN

Malignant neoplasm progression, Recurrent cancer, Glioblastoma,

24963813

FR

Hormone receptor positive HER2 negative breast cancer, Malignant neoplasm progression, Hepatic failure, Hepatic encephalopathy, Neutrophil count decreased, Anaemia, Neutrophil count decreased,

RIBOCICLIB, ENOXAPARIN SODIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, FOLIC ACID, MORPHINE SULFATE, MORPHINE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, OCTREOTIDE ACETATE, OCTREOTIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE,

24964048

US

Malignant neoplasm progression, Drug ineffective for unapproved indication,

CAPECITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, CISPLATIN,

24965488

IT

Metastases to peritoneum, Hepatic failure, Malignant neoplasm progression, Anaemia, Thrombocytopenia, Gastrointestinal toxicity, Ascites, Condition aggravated, Diarrhoea, Oedema peripheral, Alanine aminotransferase increased, Aspartate aminotransferase increased,

SELPERCATINIB, SELPERCATINIB, SELPERCATINIB, PEMETREXED, PEMETREXED DISODIUM, CISPLATIN, PEMBROLIZUMAB,

24965676

IT

Product use in unapproved indication, Drug effective for unapproved indication, Off label use, Pneumonia aspiration, Oesophageal carcinoma, Malignant neoplasm progression,

TRALOKINUMAB-LDRM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION,

24966150

US

Malignant neoplasm progression,

ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN,

24966744

CA

Ovarian cancer, Malignant neoplasm progression, Off label use,

LETROZOLE, LETROZOLE TABLETS,

24967010

JP

Neuroendocrine tumour, Malignant neoplasm progression,

EVEROLIMUS,

24967105

DE

Malignant neoplasm progression,

PEMBROLIZUMAB,

24967203

JP

Malignant neoplasm progression, Hepatic enzyme abnormal,

PEMBROLIZUMAB, FLUOROURACIL, CISPLATIN,

24969399

Malignant neoplasm progression, Therapy cessation,

ALECTINIB HYDROCHLORIDE,

24957717

CA

Malignant neoplasm progression, Ovarian cancer, Abdominal pain, Nausea,

LETROZOLE, LETROZOLE TABLETS,

24957754

JP

Malignant neoplasm progression, Metastases to meninges, Metastases to lung, Metastases to central nervous system, Therapy partial responder, Acquired gene mutation,

AFATINIB, OSIMERTINIB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION,

24958879

IT

Death, Malignant neoplasm progression, Off label use,

TRIPTORELIN, TRIPTORELIN, BICALUTAMIDE, NERATINIB,

24959284

GB

Death, Malignant neoplasm progression, Drug ineffective, Gastrointestinal disorder, Off label use,

PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, ACETAZOLAMIDE SODIUM, ACETAZOLAMIDE, ACETAZOLAMIDE SODIUM, ACETAZOLAMIDE, ACETAZOLAMIDE SODIUM, ACETAZOLAMIDE, ETOPOSIDE, DOXORUBICIN, SODIUM HYALURONATE, SODIUM HYALURONATE, SODIUM HYALURONATE, BIMATOPROST, BIMATOPROST, BRIMONIDINE TARTRATE, BRIMONIDINE TARTRATE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, TIMOLOL MALEATE, TIMOLOL MALEATE OPHTHALMIC, RETINOL, LATANOPROST, CARBOPLATIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION,

24959334

TR

Acute respiratory distress syndrome, Malignant neoplasm progression, Drug ineffective, Bronchopulmonary aspergillosis, Haemophilus infection, Bacterial sepsis,

METHOTREXATE, METHOTREXATE SODIUM, ETOPOSIDE, NELARABINE, NELARABINE INJECTION, FLUDARABINE PHOSPHATE, METHYLPREDNISOLONE, DARATUMUMAB, AZACITIDINE, AZACITIDINE FOR, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, VENETOCLAX, VENETOCLAX, VENETOCLAX, MICAFUNGIN, MICAFUNGIN SODIUM,

24959460

CA

Malignant neoplasm progression, Ovarian cancer, Nausea, Abdominal pain,

LETROZOLE, LETROZOLE TABLETS,